Sort
15,273 grants matching “antimicrobial resistance”
Mapping host-microbe-metabolite interactions in 3D to find diet-derived enhancers of immunity
$1,102,500Robin Knight · University Of California, San Diego · DP1 · FY2019 · AT
Oxadiazole Inhibitors of Non-Stop Ribosome Rescue to treat MDR Neisseria gonorrhoeae
$1,100,543Zachary David Aron · Microbiotix, Inc · R01 · FY2019 · AI
Advanced Development of a Combined Shigella-ETEC Vaccine
$1,098,552Eileen M. Barry · University Of Maryland Baltimore · R01 · FY2025 · AI
Discovering antimicrobials acting against MDR pathogens
$1,095,522Kim Lewis · Northeastern University · R01 · FY2024 · AI
Discovering antimicrobials acting against MDR pathogens
$1,095,522Kim Lewis · Northeastern University · R01 · FY2025 · AI
Acne: a disease of lipid metabolism, microbiome and the immune response
$1,093,670Robert L Modlin · University Of California Los Angeles · P50 · FY2023 · AR
Exploiting Riboswitch Sensors to Reveal Antibiotics Uptake and Retention in Gram Negative Bacteria
$1,090,845Ronald R Breaker · Yale University · R01 · FY2021 · AI
Studies of Chemokine-Receptor Interactions with Chemokines and alarmins
$1,090,780Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Acne: a disease of lipid metabolism, microbiome and the immune response
$1,089,937Robert L Modlin · University Of California Los Angeles · P50 · FY2024 · AR
Rapid, Breath Volatile Metabolite-Based Diagnostic for In Vivo Identification and Antibiotic Resistance Profiling of Bacterial Pathogens in Ventilator-Associated Pneumonia
$1,089,217Sophia Koo · Brigham And Women'S Hospital · R01 · FY2020 · AI
Optimized Combination Antimalarial Drug Therapy
$1,087,190Paul D. Roepe · Georgetown University · R01 · FY2015 · AI
Drug resistance enablers and their role in antibiotic treatment failure
$1,085,284Vaughn Cooper · Boston Children'S Hospital · U19 · FY2024 · AI
Short and long term outcomes of doxycycline versus TMP-SMX for SSTI treatment
$1,083,522Loren G Miller · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U01 · FY2021 · AI
Chemistry Core
$1,081,381Timothy S Bugni · University Of Wisconsin-Madison · U19 · FY2020 · AI
Biochemistry of Energy-Dependent (Intracellular) Protein Degradation
$1,079,940Michael Maurizi · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Point-of-care antimicrobial susceptibility testing based on simultaneous tracking of multi-phenotypic features of single bacterial cells
$1,079,736Shaopeng Wang · Arizona State University-Tempe Campus · R01 · FY2022 · AI
Point-of-care antimicrobial susceptibility testing based on simultaneous tracking of multi-phenotypic features of single bacterial cells
$1,079,736Shaopeng Wang · Arizona State University-Tempe Campus · R01 · FY2021 · AI
Clinical Trial for CA-MRSA Infections
$1,077,815Denise Tritt · Olive View-Ucla Education And Res Inst · N01 · FY2012 · AI
Novel bi-specific immunoprophylactics against multi-drug resistant Gram-negativebacterial infections
$1,076,832David S Perlin · Hackensack University Medical Center · R01 · FY2022 · AI
Novel bi-specific immunoprophylactics against multi-drug resistant Gram-negative bacterial infections
$1,076,832David S Perlin · Hackensack University Medical Center · R01 · FY2021 · AI
AI-3 Inhibitors as treatment for bacterial infections
$1,075,870Vanessa Sperandio · Ut Southwestern Medical Center · U01 · FY2012 · AI
Studies of Chemokine-Receptor Interactions with Chemokines and alarmins
$1,072,297Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
A multiscale approach to develop and apply fluoride efflux inhibitors to reverse oral dysbiosis and eliminate early childhood caries
$1,071,751Randy B. Stockbridge · University Of Michigan At Ann Arbor · RM1 · FY2025 · DE
Consortium for drug-resistant Gram-negative pathogen detection
$1,071,131Lee W Riley · University Of California Berkeley · R01 · FY2019 · AI
Novel bi-specific immunoprophylactics against multi-drug resistant Gram-negative bacterial infections
$1,070,621David S Perlin · Hackensack University Medical Center · R01 · FY2019 · AI